Exposure to stress in different periods of life represents a risk factor for the development of psychiatric disorders. Here we used two different experimental paradigms, the prenatal stress (PNS) model and the chronic mild stress (CMS) model to identify brain alterations caused by exposure to stress early in life or at adulthood, and to investigate the ability of the antipsychotic drug lurasidone to prevent or counteract the stress-induced abnormalities.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Biological Psychiatry
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2020 Published by Elsevier Inc.